Xlinktx
1 known investors
Crosslink develops a modular biologic domain that assembles therapeutics within tumors to improve tumor-specific targeting and activity. The company applies this platform to antibody drug conjugates and radioligand therapies in oncology.
Investors · 1
Frequently asked questions
- What does Xlinktx do?
- Crosslink develops a modular biologic domain that assembles therapeutics within tumors to improve tumor-specific targeting and activity. The company applies this platform to antibody drug conjugates and radioligand therapies in oncology.
- Who are Xlinktx's investors?
- Xlinktx's investors include Cure Ventures.